$ Value
$565K
Shares
2,900
Price
$195
Filed
Mar 10
Insider
Name
RABINOWITZ DANIEL
Title
SEC. AND CHIEF LEGAL OFFICER
CIK
0001857843
Roles
Transaction Details
Transaction Date
2026-03-06
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
238,383
Footnotes
The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.27 to $194.02 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.27 to $195.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.32 to $196.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.42 to $197.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.45 to $198.32 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The option shares are fully exercisable.
Filing Info
RABINOWITZ DANIEL's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | NTRA | ▼ | $60K |
| 2026-04-01 | NTRA | ▼ | $359K |
| 2026-04-01 | NTRA | ▼ | $652K |
| 2026-04-01 | NTRA | ▼ | $245K |
| 2026-04-01 | NTRA | ▼ | $391K |
| 2026-03-10 | NTRA | ▼ | $356K |
| 2026-03-09 | NTRA | A | — |
| 2026-03-06 | NTRA | M | $110K |
| 2026-03-06 | NTRA | ▼ | $77K |
| 2026-03-06 | NTRA | ▼ | $565K |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $3.9M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |